Angiotensin Receptor–Binding Protein ATRAP/Agtrap Inhibits Metabolic Dysfunction With Visceral Obesity

BACKGROUND: Metabolic disorders with visceral obesity have become a major medical problem associated with the development of hypertension, type 2 diabetes, and dyslipidemia and, ultimately, life‐threatening cardiovascular and renal diseases. Adipose tissue dysfunction has been proposed as the cause...

Descripción completa

Detalles Bibliográficos
Autores principales: Maeda, Akinobu, Tamura, Kouichi, Wakui, Hiromichi, Dejima, Toru, Ohsawa, Masato, Azushima, Kengo, Kanaoka, Tomohiko, Uneda, Kazushi, Matsuda, Miyuki, Yamashita, Akio, Miyazaki, Nobuko, Yatsu, Keisuke, Hirawa, Nobuhito, Toya, Yoshiyuki, Umemura, Satoshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2013
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3828814/
https://www.ncbi.nlm.nih.gov/pubmed/23902639
http://dx.doi.org/10.1161/JAHA.113.000312

Ejemplares similares

Ejemplares similares